d) - auch als Quereinstieg möglich at Acadia Pharmaceuticals

Kiel, Schleswig-Holstein, Germany

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Candidates should possess an apprenticeship as a pharmacist (Pharmacie), chemist (Chemie), or a comparable vocational training in a technical field such as chemistry, biology, pharmacy, medicine, or food technology. Prior experience in the manufacture of sterile pharmaceuticals is desirable. Applicants should have an understanding of GMP-compliant documentation and behavior in cleanrooms, as well as good knowledge of MS Office programs, especially Excel and Outlook.

Responsibilities

The Operator Sterile Production will prepare materials and equipment for production, operate complex production machinery for the sterile filling of pharmaceuticals, complete thorough documentation of all processes, assist with machine maintenance, contribute to the creation and upkeep of work instructions, record production orders in the warehouse management system, handle highly potent substances safely, and demonstrate teamwork, communication skills, and a cooperative attitude.

Skills

Machine Operation

GMP Documentation

Cleanroom Procedures

Hygiene Awareness

Technical Processes

MS Office

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free